# A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo

> **NCT07241377** · PHASE3 · RECRUITING · sponsor: **RDC Clinical Pty Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Absorption of Omega-3
- Omega-3 Supplementation
- Healthy Participants

## Interventions

- **DIETARY_SUPPLEMENT:** life'sTM omega O1035DS nTG
- **DIETARY_SUPPLEMENT:** life'sTM omega O3020DS nTG
- **DIETARY_SUPPLEMENT:** MEG-3 3323rTG
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07241377
- **Lead sponsor:** RDC Clinical Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-27
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07241377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07241377, "A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT07241377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*